Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, attendees will learn about how AI-guided technologies can be used to quantify digital pathology images. Presenters will discuss different deployment models for AI in pathology and how to identify projects that will benefit from AI. Four practical-use cases for AI in drug discovery and safety assessment will also be presented.

Xtalks Life Science Webinars

While AI holds great promise in digital pathology, it is key to understand both the advantages and limitations of the technology, the technical requirements for different deployments and financial practicalities.

Join Daniel Sutton, Senior Scientist, Digitisation and AI, Clinical Pharmacology and Safety Science at AstraZeneca for an informative session about AI-based models in the quantification of pathology images. There will be two live broadcasts, on Monday, May 11, 2020 at 11am EDT (4pm BST/UK) and Tuesday, May 12, 2020 at 9am BST/UK.

Artificial intelligence (AI) is revolutionizing drug discovery and development to help scientists make data-driven decisions faster and more efficiently. Pathology is no exception and the Pathology Sciences team at AstraZeneca in Cambridge UK is leading the way. At AstraZeneca, Indica Labs’ HALO AI and other AI solution platforms are being used to examine digital pathology images for specific tissue classes, features and pathologies that are not easily quantified using traditional image analysis techniques or are too time-consuming for pathologists to quantify by eye.

While AI holds great promise in digital pathology, it is key to understand both the advantages and limitations of the technology, the technical requirements for different deployments and financial practicalities. In this one-hour webinar, Daniel Sutton will address these key points and will describe specific-use cases where AI has benefited pathology assessments and improved efficiency within his group at AstraZeneca. Prior to the main presentation, Dr. Kate Lillard Tunstall, Chief Scientific Officer at Indica Labs, will give a brief introduction to Indica Labs’ HALO AI solution.

Join this free webinar to learn more about cutting edge AI solutions in pathology image analysis.

For more information or to register for this event, visit Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website